Literature DB >> 10524622

Commitment to the B-lymphoid lineage depends on the transcription factor Pax5.

S L Nutt1, B Heavey, A G Rolink, M Busslinger.   

Abstract

The Pax5 gene encoding the B-cell-specific activator protein (BSAP) is expressed within the haematopoietic system exclusively in the B-lymphoid lineage, where it is required in vivo for progression beyond the pro-B-cell stage. However, Pax5 is not essential for in vitro propagation of pro-B cells in the presence of interleukin-7 and stromal cells. Here we show that pro-B cells lacking Pax5 are also incapable of in vitro B-cell differentiation unless Pax5 expression is restored by retroviral transduction. Pax5-/- pro-B cells are not restricted in their lineage fate, as stimulation with appropriate cytokines induces them to differentiate into functional macrophages, osteoclasts, dendritic cells, granulocytes and natural killer cells. As expected for a clonogenic haematopoietic progenitor with lymphomyeloid developmental potential, the Pax5-/- pro-B cell expresses genes of different lineage-affiliated programmes, and restoration of Pax5 activity represses this lineage-promiscuous transcription. Pax5 therefore plays an essential role in B-lineage commitment by suppressing alternative lineage choices.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10524622     DOI: 10.1038/44076

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  311 in total

1.  Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family.

Authors:  D Eberhard; G Jiménez; B Heavey; M Busslinger
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

2.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  A Hodgkin's disease cell line, KM-H2, shows biphenotypic features of dendritic cells and B cells.

Authors:  K Uehira; R Amakawa; T Ito; T Uehira; Y Ozaki; T Shimizu; M Fujimoto; M Inaba; S Fukuhara
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

4.  T-bet regulates IgG class switching and pathogenic autoantibody production.

Authors:  Stanford L Peng; Susanne J Szabo; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

5.  Isolation, maturational level, and functional capacity of human colon lamina propria plasma cells.

Authors:  F Medina; C Segundo; A Campos-Caro; I Salcedo; A García-Poley; J A Brieva
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

6.  Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development.

Authors:  Toni Portis; Richard Longnecker
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  Nephric lineage specification by Pax2 and Pax8.

Authors:  Maxime Bouchard; Abdallah Souabni; Markus Mandler; Annette Neubüser; Meinrad Busslinger
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

Review 8.  Factors and networks that underpin early hematopoiesis.

Authors:  Elinore M Mercer; Yin C Lin; Cornelis Murre
Journal:  Semin Immunol       Date:  2011-09-18       Impact factor: 11.130

9.  Nuclear reprogramming in cell-free extracts.

Authors:  Philippe Collas
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-08-29       Impact factor: 6.237

10.  Epigenetic silencing of the c-fms locus during B-lymphopoiesis occurs in discrete steps and is reversible.

Authors:  Hiromi Tagoh; Alexandra Schebesta; Pascal Lefevre; Nicola Wilson; David Hume; Meinrad Busslinger; Constanze Bonifer
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.